Enterix
Latest round
- Series A
Last raised
- Jul 2001
Total raised
- $7.5M
Investors
- 3
About Enterix
Enterix is focused on developing accessible screening solutions for colorectal cancer. The company is headquartered in Sydney, Australia, and has undergone a pivotal change when it was acquired by Quest Diagnostics Incorporated for USD 44 mn on June 6, 2006.Enterix specializes in its core product, InSure One, which is a unique Fecal Immunochemical Test (FIT) facilitating easy colorectal cancer screening. It allows users to collect samples with a brush in toilet water, enhancing comfort and privacy.Following the acquisition by Quest Diagnostics, Enterix plans to leverage the resources to enhance product development and expand its market reach.
Who invested in Enterix
3 investors across 1 round
See all investors in Enterix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 26, 2001
Amount
$7.5M
Investors
Questions about Enterix
Who invested in Enterix?
Enterix has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enterix raised?
Enterix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Enterix last raise money?
Enterix's most recent round on record is a Series A, in Jul 2001.
What does Enterix do?
Enterix is focused on developing accessible screening solutions for colorectal cancer.
Where is Enterix headquartered?
Enterix is headquartered in Sydney, Australia.
Which VCs invest in companies like Enterix?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back biotechnology companies at Enterix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Enterix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.